DA1 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context of DA1 Antibody

The term "DA1 antibody" refers to a specific autoantibody identified in patients with systemic lupus erythematosus (SLE). DA1 and its associated DA2 antibody form precipitin systems targeting nuclear proteins derived from human spleen extracts. DA1 antibodies are rare, appearing in 5% of SLE patients, and are always co-expressed with DA2 antibodies (found in ~22% of SLE cases) . These antibodies are linked to distinct clinical manifestations, including photosensitivity, hepatosplenomegaly, and CNS involvement .

Clinical and Serological Characteristics

DA1 antibodies are associated with specific pathological features in SLE:

Clinical FeatureAssociation with DA1 Antibody
PhotosensitivityIncreased incidence (p<0.001p < 0.001)
HepatosplenomegalyIncreased incidence (p<0.001p < 0.001)
Hemolytic anemiaIncreased incidence (p<0.05p < 0.05)
Diffuse proliferative glomerulonephritisHigher prevalence
ThrombocytopeniaNo direct association (linked to DA2)

DA1 antibodies produce a speckled staining pattern on HEp2 cells and rat kidney tissues, suggesting reactivity with nuclear antigens . Unlike other SLE-associated antibodies (e.g., anti-Sm or anti-Ro), DA1 exhibits a unique serological profile and is proposed to represent a novel autoantibody system in SLE .

Research Findings and Mechanistic Insights

  • Pathogenic Role: DA1-positive SLE patients show heightened severity, including vasculitis and CNS involvement, compared to DA1-negative cohorts .

  • Serological Association: DA1 and DA2 antibodies are tightly linked, mirroring relationships seen between other SLE autoantibody pairs (e.g., anti-Sm and anti-nRNP) .

  • Molecular Targets: While the exact nuclear protein targets of DA1 remain uncharacterized, indirect evidence suggests DA1 may overlap with the previously described MA antibody system .

Comparative Analysis with Other Antibody Systems

DA1 antibodies differ from other antibody classes (e.g., IgG, IgE) in structure and function:

Antibody TypeMolecular WeightRole
DA1 (SLE-associated)Not specifiedAutoimmune targeting of nuclear proteins
IgG~150,000 DaPrimary serum antibody; neutralizes pathogens
IgE~200,000 DaMediates allergic responses

Unlike therapeutic antibodies (e.g., anti-DLL1 or anti-DDR1 antibodies used in cancer ), DA1 antibodies are strictly pathological and lack direct therapeutic applications.

Implications for SLE Diagnosis and Management

  1. Identify precise DA1 antigen targets.

  2. Clarify its role in SLE pathogenesis.

  3. Explore potential therapeutic strategies to modulate DA1 activity.

Current diagnostic workflows for SLE should consider DA1/DA2 testing in patients with atypical organ involvement or refractory disease .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
DA1 antibody; SOD1 antibody; At1g19270 antibody; T29M8.14Protein DA1 antibody; Protein SUPPRESSOR OF LARGE SEED AND ORGAN PHENOTYPES OF DA1-1 1 antibody
Target Names
DA1
Uniprot No.

Target Background

Function

The DA1 antibody targets a ubiquitin receptor that plays a crucial role in regulating final seed and organ size by controlling the duration of cell proliferation. Evidence suggests a maternal role in seed mass control, acting synergistically with DA2 to achieve this. This synergistic action extends to restricting cell proliferation within the maternal integuments of ovules and developing seeds. Conversely, DA1 functions antagonistically with UBP15 in a shared pathway to regulate seed size. DA1 physically interacts with UBP15, modulating its stability and influencing cell proliferation in ovules and developing seeds. DA1 functions as a peptidase, cleaving the N-terminal sequences of the E3 ubiquitin-protein ligases BB and DA2 in a ubiquitin-dependent manner. Further peptidase activity is observed through the cleavage of the deubiquitinating enzyme UBP15 (which promotes cell proliferation), and the transcription factors TCP15 and TCP22 (which promote cell proliferation and repress endoreduplication). Beyond its role in growth restriction, DA1 is involved in promoting leaf senescence. Redundancy with DAR1 and DAR2 in regulating endoreduplication during leaf development has also been observed. In collaboration with DAR1 and DAR2, DA1 modulates the protein stability of transcription factors TCP14 and TCP15, which repress endoreduplication by directly regulating the expression of cell-cycle genes.

Gene References Into Functions
  1. DA1's role in controlling leaf growth and senescence. PMID: 28003326
  2. DA1's peptidase activity coordinates the destabilization of regulatory proteins, influencing the duration of cell proliferation and the transition to endoreduplication and differentiation during organ formation. PMID: 28167503
  3. Overexpression of da1-1 cDNA significantly increases seed and organ size in wild-type plants. PMID: 18483219
Database Links

KEGG: ath:AT1G19270

STRING: 3702.AT1G19270.1

UniGene: At.21826

Q&A

What is DA1 Antibody and what is its target protein?

DA1 antibody is a research reagent developed to detect and study the DA1 protein, which plays a critical role in controlling seed and organ size in plants. The name "DA" derives from the Chinese word meaning "large," reflecting the enlarged phenotype observed in da1-1 mutants . The target protein, DA1, is a 532-amino acid protein in Arabidopsis thaliana that functions to limit the proliferative growth period during early stages of organ development . Unlike antibodies targeting DLL1 (Delta-like protein 1), which is involved in Notch signaling pathways in mammals , DA1 antibody specifically recognizes plant growth regulators.

What are the primary applications of DA1 antibody in plant science?

DA1 antibody has several important applications in plant science research:

  • Protein detection: Used in Western blot assays to detect DA1 protein expression levels in different plant tissues or developmental stages

  • Ubiquitin-binding studies: Applied in assays examining the ubiquitin-binding activity of wild-type DA1 and mutant variants like DA1R358K

  • Immunoprecipitation: Employed to isolate DA1 protein complexes to identify interacting partners

  • Localization studies: Utilized in immunohistochemistry to determine the subcellular localization of DA1 during plant development

These applications allow researchers to investigate the molecular mechanisms through which DA1 controls organ size and development in plants.

How does DA1 antibody help in understanding plant growth regulation?

DA1 antibody provides a powerful tool for studying the role of DA1 in controlling plant organ size. Research has shown that da1-1 mutants exhibit increased seed mass (132% of wild type), larger embryos, and increased cotyledon areas . By using DA1 antibody in comparative studies between wild-type and mutant plants, researchers can:

  • Track DA1 protein levels during developmental transitions

  • Correlate DA1 expression with cell proliferation arrest

  • Identify tissues where DA1 is most active in growth regulation

  • Examine how post-translational modifications affect DA1 function

The antibody allows researchers to move beyond genetic studies to directly investigate protein-level mechanisms controlling plant organ size.

How can DA1 antibody be used to investigate ubiquitin-binding activity?

DA1 antibody can be instrumental in studying the ubiquitin-binding properties of DA1 protein, which appears critical to its function. Research has shown that there was no significant difference in ubiquitin-binding activity between GST-DA1 and GST-DA1R358K proteins , despite the R358K mutation causing dramatic phenotypic changes in plant development.

To investigate ubiquitin-binding activity using DA1 antibody, researchers can:

  • Perform pull-down assays with ubiquitin-conjugated beads

  • Use DA1 antibody in Western blots to detect wild-type or mutant DA1 proteins retained in ubiquitin-binding assays

  • Compare binding affinity between different DA1 variants through quantitative immunoblotting

  • Conduct competitive binding assays using DA1 antibody to detect displacement of DA1 from ubiquitin by other proteins

These approaches help elucidate the molecular mechanism through which DA1 regulates plant organ size via the ubiquitin pathway.

What experimental design considerations are important when using DA1 antibody in developmental studies?

When designing experiments with DA1 antibody for developmental studies, researchers should consider:

  • Temporal sampling: Since DA1 functions to limit the period of proliferative growth , sampling must capture the critical developmental windows

  • Tissue specificity: Different organs may show varying patterns of DA1 expression and activity

  • Genetic backgrounds: Compare wild-type, da1-1 mutant, and complemented lines expressing wild-type DA1 cDNA

  • Controls: Include appropriate negative controls (pre-immune serum) and positive controls (recombinant DA1 protein)

  • Analytical methods: Combine immunological techniques with cell cycle markers (e.g., CYCB1;1 reporter fusion) to correlate DA1 function with cell proliferation arrest

A comprehensive experimental design helps resolve contradictory findings and establishes causative relationships between DA1 activity and phenotypic outcomes.

How can DA1 antibody help resolve contradictions in genetic versus biochemical data?

Research has revealed interesting contradictions between genetic and biochemical data regarding DA1 function. For example, the da1-1 mutation (R358K) causes dramatic phenotypic changes despite no significant difference in ubiquitin-binding activity compared to wild-type DA1 . DA1 antibody can help resolve such contradictions through:

  • Interaction studies: Using DA1 antibody in co-immunoprecipitation experiments to identify differential protein interactions between wild-type and mutant DA1

  • Conformational analysis: Employing limited proteolysis followed by DA1 antibody detection to examine potential structural differences

  • Post-translational modification profiling: Analyzing differences in phosphorylation, ubiquitination, or other modifications between wild-type and mutant DA1

  • Subcellular localization: Determining whether the mutation affects localization, which might not be reflected in simple binding assays

These approaches provide mechanistic insights beyond genetic observations and simple binding studies.

What is the optimal protocol for using DA1 antibody in immunodetection assays?

For optimal results when using DA1 antibody in immunodetection assays, researchers should follow these methodological guidelines:

  • Sample preparation:

    • For plant tissues: Extract proteins in buffer containing protease inhibitors

    • Process samples quickly to prevent degradation

    • Consider developmental stage carefully based on DA1's role in controlling the timing of growth arrest

  • Western blotting:

    • Use appropriate dilution (typically 1:1000-1:5000, but optimize for your specific antibody)

    • Include positive controls (e.g., recombinant DA1 protein)

    • Include negative controls (e.g., da1 knockout plant extracts)

  • Immunohistochemistry:

    • Fix tissues appropriately (typically 4% paraformaldehyde)

    • Perform antigen retrieval if necessary

    • Use secondary antibody controls to verify specificity

    • Counter-stain nuclei to help determine subcellular localization

These protocols may require optimization for specific plant species, tissues, or developmental stages.

How can researchers validate the specificity of DA1 antibody?

Validating antibody specificity is crucial for reliable research outcomes. For DA1 antibody, consider these validation approaches:

  • Genetic controls:

    • Test antibody reactivity in wild-type plants versus da1 knockout mutants

    • Confirm signal restoration in complemented lines expressing wild-type DA1 cDNA

  • Biochemical validation:

    • Pre-absorption tests with recombinant DA1 protein

    • Peptide competition assays with the immunizing peptide

    • Western blot analysis showing a single band of the expected molecular weight

  • Cross-reactivity assessment:

    • Test reactivity against related proteins (e.g., DAR1, DAR2)

    • Evaluate specificity across different plant species if working with non-model organisms

Proper validation ensures experimental results accurately reflect DA1 biology rather than artifacts or cross-reactivity.

What sample preparation methods optimize DA1 antibody performance?

Optimal sample preparation is essential for successful DA1 antibody applications:

  • Protein extraction:

    • Use buffers containing appropriate detergents (e.g., 0.1% SDS or 1% Triton X-100)

    • Include protease inhibitors to prevent degradation

    • Consider phosphatase inhibitors if studying phosphorylation states

    • Extract at 4°C to minimize protein degradation

  • Tissue fixation for immunohistochemistry:

    • For plant tissues, 4% paraformaldehyde is typically effective

    • Optimize fixation time based on tissue thickness

    • Consider embedding method based on tissue type (paraffin vs. cryosectioning)

  • Antigen retrieval methods:

    • Heat-induced epitope retrieval may be necessary for fixed tissues

    • Try citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0) for heat-mediated antigen retrieval

    • Test enzymatic retrieval methods if heat-induced methods are unsuccessful

These preparations help preserve epitope structure and accessibility, maximizing antibody performance.

How can DA1 antibody complement genetic approaches in studying plant development?

DA1 antibody provides protein-level insights that complement genetic approaches:

  • Genotype-phenotype correlation:

    • While genetic studies showed da1-1 mutation increases seed and organ size , antibody-based approaches can reveal whether this correlates with altered protein levels, modified localization, or changed interaction partners

  • Temporal resolution:

    • Genetic approaches may indicate that DA1 controls organ size, but antibody-based studies can pinpoint exactly when and where DA1 protein acts during development

  • Mechanistic insights:

    • Genetics identified the importance of the R358K mutation (da1-1) , but antibody-based biochemical studies revealed this doesn't affect ubiquitin binding, suggesting other mechanisms

  • Interaction networks:

    • Combine DA1 antibody immunoprecipitation with mass spectrometry to identify DA1 interaction partners, complementing genetic interaction studies

This integration provides a more comprehensive understanding of DA1 function in plant development.

What are the considerations for using DA1 antibody across different plant species?

When applying DA1 antibody in cross-species research:

  • Sequence conservation assessment:

    • Analyze sequence homology of DA1 between your species of interest and the immunogen used to generate the antibody

    • Focus on epitope regions if known

  • Validation in each species:

    • Perform Western blots to confirm the antibody recognizes a band of appropriate molecular weight

    • Include positive controls (e.g., Arabidopsis extracts) alongside new species samples

    • Consider knockout/knockdown controls in the new species if available

  • Optimization for each species:

    • Adjust antibody concentration and incubation conditions

    • Modify extraction buffers based on species-specific tissue characteristics

    • Test multiple fixation protocols for immunohistochemistry

These considerations help ensure reliable results when extending DA1 research beyond model organisms.

How can researchers address common challenges with DA1 antibody applications?

When encountering difficulties with DA1 antibody applications, consider these troubleshooting approaches:

ChallengePotential Solutions
Weak or no signal in Western blot- Increase antibody concentration
- Extend incubation time
- Enhance protein loading
- Try different membrane types
- Use more sensitive detection methods
High background- Increase blocking time or concentration
- Use more stringent washing
- Decrease antibody concentration
- Try different blocking agents
- Pre-absorb antibody with non-specific proteins
Multiple bands- Use fresh samples with protease inhibitors
- Optimize sample preparation
- Consider native vs. denaturing conditions
- Test specificity with knockout controls
Inconsistent results- Standardize protein extraction methods
- Control for plant growth conditions
- Consider developmental timing
- Use internal loading controls

Systematic troubleshooting can help overcome technical challenges in DA1 antibody applications.

How can advanced imaging techniques enhance DA1 antibody-based research?

Advanced imaging approaches can significantly extend the utility of DA1 antibody:

  • Super-resolution microscopy:

    • Techniques like STORM or PALM can reveal nanoscale localization of DA1 protein

    • Helpful for studying DA1 distribution within subcellular compartments

  • Multiplex immunolabeling:

    • Combine DA1 antibody with antibodies against cell cycle markers or potential interacting proteins

    • Use spectrally distinct fluorophores to visualize multiple proteins simultaneously

  • Live cell imaging approaches:

    • Complement antibody studies with fluorescent protein fusions to DA1

    • Compare fixed-cell antibody results with live-cell dynamics

  • 3D reconstruction:

    • Use confocal z-stacks with DA1 antibody staining to create 3D models of DA1 distribution within tissues

    • Helpful for understanding spatial regulation of plant development

These approaches provide spatial and temporal context to biochemical findings about DA1 function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.